Clinical Trial Update: Nalbuphine Versus Dexmedetomidine for Prevention of Emergence Agitation in Pediatrics [Phase 4]

View source ↗

Summary

Phase 4 trial comparing nalbuphine to dexmedetomidine for prevention of emergence agitation in pediatric patients; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Agitation

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Nalbuphine (nalbuphine)

Snippet

Sponsor: Alexandria University | Conditions: Agitation | Phase 4 | Status: UNKNOWN